| Patents for C07C 271 - Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups (15,621) |
|---|
| 02/04/2003 | US6515025 Use of ethynyl alanine amino diol compounds to inhibit enzymatic conversion of angiotensinogen to angiotensin I |
| 02/04/2003 | US6514998 For controlling animal pests and harmful fungi |
| 02/04/2003 | US6514925 O-substituted N,N-diacylhydroxylamine bleach activators and compositions employing the same |
| 01/31/2003 | WO2002012169A1 Amino diphenyl ethers and amido diphenyl ethers |
| 01/31/2003 | CA2417880A1 Amino diphenyl ethers and amido diphenyl ethers |
| 01/30/2003 | WO2003008373A1 Tyrosine hydrazides |
| 01/30/2003 | WO2003008372A1 Diamine derivative, process for producing the same, and bactericide containing the same as active ingredient |
| 01/30/2003 | US20030023111 Process for the production of 1,2,4-triaminobenzene carbamic acid esters |
| 01/30/2003 | US20030023017 Diethyloctandioldicarbamates and diethyloctandioldiallophanates, method for the production and use thereof |
| 01/30/2003 | US20030021773 Arginine mimetics as factor Xa inhibitors |
| 01/29/2003 | EP1278741A1 Muscarinic agonists |
| 01/29/2003 | EP1278716A1 Cyclohexylamine derivative as subtype selective nmda receptor antagonists |
| 01/29/2003 | CN1394199A Peptide derivatives and their pharmaceutically acceptable salts, processes for preparation of both, and use thereof |
| 01/29/2003 | CN1100058C Novel intermediates and process for manufacture of camptothecin derivatives (CPT-11) and related compounds |
| 01/28/2003 | US6511990 Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof |
| 01/23/2003 | WO2003006423A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 01/23/2003 | WO2003006422A1 New derivatives of substituted anilines with herbicidal activity |
| 01/23/2003 | WO2003006021A1 Alpha-hydroxyamide statine derivatives for the treatment of alzh eimer's disease |
| 01/23/2003 | WO2003006013A1 Diaminediols for the treatment of alzheimer's disease |
| 01/23/2003 | WO2002022559A3 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 01/23/2003 | US20030018207 Pharmaceutical medication associated with insulin resistance; patient with prophylaxis conditions having reduced sensitivity to insulin |
| 01/23/2003 | US20030018195 Alpha-aminoacetic acid derivatives- alpha4beta7 receptor antagonists |
| 01/23/2003 | US20030018190 Valency platform molecules comprising carbamate linkages |
| 01/23/2003 | US20030018055 Serine carbonates |
| 01/23/2003 | US20030018016 Cell adhesion inhibitors |
| 01/23/2003 | CA2453503A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 01/23/2003 | CA2453447A1 Alpha-hydroxyamide statine derivatives for the treatment of alzheimer's disease |
| 01/23/2003 | CA2453444A1 Diaminediols for the treatment of alzheimer's disease |
| 01/22/2003 | EP1277729A1 Ppar (gamma) modulators |
| 01/22/2003 | EP1276714A2 Cyclic carboxylic acids as integrin antagonists |
| 01/22/2003 | EP1276713A1 Inhibition of angiogenesis and tumor growth |
| 01/22/2003 | EP1030838B1 Method of synthesis of pyrrole amides |
| 01/22/2003 | CN1099425C 新的肽衍生物 New peptide derivatives |
| 01/21/2003 | US6509484 Trifluoroacetic acid amine salt taxane derivatives useful for taxol production |
| 01/21/2003 | US6509369 Triphenylpropanamide compounds; useful in treating inflammations but which do not demonstrate side effects associated with other anti-inflammatory treatments such as glucocorticoids |
| 01/16/2003 | WO2001062705A3 Aminoalcohol derivatives |
| 01/16/2003 | US20030013881 Such as 4-((6-(3,5-difluoro-phenyl)-5-(S)-(3-dipropylcarb-amoyl-benzoyl-amino)-2-(R)-ethyl-4-(S)-hydroxy-hexanoylamino)-methyl)-cyclohexanecarboxylic acid for inhibiting secretase activity and cleavage of amyloid precursor protein |
| 01/16/2003 | US20030013760 Substituted 1-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 01/16/2003 | US20030013725 Amino acid derivatives |
| 01/16/2003 | US20030013719 Ortho, meta-substituted bisaryl compounds, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them |
| 01/16/2003 | US20030013707 Enzyme inhibitor |
| 01/16/2003 | US20030010963 Organic electrochromic materials and polymers for optical attenuation in the near infrared region |
| 01/15/2003 | EP1275389A1 Compositions containing C7 Taxanes |
| 01/15/2003 | EP0790988B1 Use of dioxomorpholines to combat endoparasites, novel dioxomorpholines and process for their production |
| 01/15/2003 | EP0729468B1 Non-peptide tachykinin receptor antagonists |
| 01/15/2003 | CN1098841C Novel amide derivatives and medicinal compositions thereof |
| 01/14/2003 | US6506811 Carbamate solutions |
| 01/14/2003 | US6506733 Compounds and compositions as protease inhibitors |
| 01/09/2003 | WO2003002519A1 Phenol derivatives and their use in medicaments |
| 01/09/2003 | WO2003002512A1 Process for producing hydroxyamino acid derivative |
| 01/09/2003 | WO2003002509A1 Chiral resolution method for producing compounds useful in the synthesis of taxanes |
| 01/09/2003 | US20030009056 Process for the removal of nitrobenzenesulfonyl |
| 01/09/2003 | US20030009030 Novel selective deacetylating agents |
| 01/09/2003 | US20030008996 Utilized for image forming materials, for example, stereolithography, holography, lithographic printing plate precursors, color proofs, photoresists and color filters, and photosetting resin materials such as ink, paint, adhesive |
| 01/09/2003 | US20030008907 Intermediates for the synthesis of benzimidazole derivatives and a process for the preparation thereof |
| 01/09/2003 | US20030008900 Compounds and compositions for delivering active agents |
| 01/09/2003 | US20030008889 Aminoadamantane derivatives as therapeutic agents |
| 01/09/2003 | US20030008884 Fungicidal phenyl (thio) urea and phenyl (thio) carbamate derivatives |
| 01/09/2003 | US20030008881 Substituted phenylcyclohexanecarboxamides and their use |
| 01/09/2003 | US20030008768 Catalyst for aromatic C-O, C-N, and C-C bond formation |
| 01/09/2003 | CA2452109A1 Chiral resolution method for producing compounds useful in the synthesis of taxanes |
| 01/08/2003 | EP1273568A2 Novel diazo derivatives and process for their preparation |
| 01/08/2003 | EP1272459A1 7- and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds |
| 01/08/2003 | EP1272458A1 Arginine mimetics as factor xa inhibitors |
| 01/08/2003 | EP1272173A1 Methods for inhibiting angiogenesis and tumor growth |
| 01/08/2003 | EP1272147A1 Dental materials with extendable work time, kits, and methods |
| 01/08/2003 | CN1389298A Microporous material carried metal complex-ionic liquid catalyst |
| 01/08/2003 | CN1098250C Process for preparing substituted valine amide derivatives |
| 01/07/2003 | US6504031 Enzyme inhibitor such as 6-(2-(1-isopropyl-1,2,3,4-tetrahydro -7-isoquinolinyl)ethenyl)-2-naphthalenecarboximidamide, used as angiogenesis inhibitors; antiarthritic, antiinflammatory and antitumor agents |
| 01/07/2003 | US6503949 Glucagon antagonists/inverse agonists |
| 01/07/2003 | US6503745 Method of detecting influenza virus, comprising the step of exposing a sample suspected to comprise influenza virus to at least one compound according to claim 1, wherein the at least one compound is capable of binding specifically to the active |
| 01/07/2003 | US6503713 Methods for identifying RNA binding compounds |
| 01/04/2003 | CA2392282A1 Novel diazo derivatives and process for their preparation |
| 01/03/2003 | WO2002042348A3 Polyols containing carboxyl groups and production thereof |
| 01/02/2003 | US20030004360 Processes and intermediates for preparing benzyl epoxides |
| 01/02/2003 | EP1268414A1 Ceramide derivatives and method of use |
| 01/02/2003 | EP1268410A1 Beta-hydroxy butenyl carbamate, functional oligomers and coatings therefrom |
| 01/02/2003 | EP1268409A1 Continuous process for the synthesis of aromatic urethanes |
| 01/02/2003 | EP1268397A2 Method for preparing (2s,3r,4s)-4-hydroxyisoleucine and analogues thereof |
| 01/02/2003 | EP0804431B9 GLYCOPROTEIN IIb/IIIa ANTAGONISTS |
| 12/31/2002 | US6500985 Process for producing alpha-aminoketones |
| 12/31/2002 | US6500812 Gastrointestinal disorders; antiinflammatory agents |
| 12/31/2002 | US6500213 Oxidizing hair coloring agents containing 2,5-diamino-1-phenylbenzene derivatives and novel 2,5-diamino-1-phenylbenzene derivatives |
| 12/27/2002 | WO2002102764A2 Method for producing chiral amino acid derivatives |
| 12/27/2002 | WO2002088127A3 Triazolopyrimidines |
| 12/27/2002 | WO2002070473A3 Carboxamide derivatives as therapeutic agents |
| 12/26/2002 | US20020198399 Useful as intermediates or raw materials for the synthesis of agricultural chemicals, pharmaceuticals |
| 12/24/2002 | US6498190 Bicyclic amino derivatives and PGD2 antagonist containing the same |
| 12/24/2002 | US6498004 Silver halide light sensitive emulsion layer having enhanced photographic sensitivity |
| 12/19/2002 | WO2002100849A2 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 12/19/2002 | WO2002100824A1 A novel alkaloid derivative and a pharmaceutical composition containing the same |
| 12/19/2002 | WO2002100812A1 Carboxylic acid derivative and salt thereof |
| 12/19/2002 | WO2002100403A1 Modulators of peroxisome proliferator activated receptors (ppar) |
| 12/19/2002 | WO2002100392A1 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity |
| 12/19/2002 | WO2002100347A2 Prodrugs of gaba analogs, compositions and uses thereof |
| 12/19/2002 | US20020193596 Inhibitors of protein isoprenyl transferases |
| 12/19/2002 | US20020193432 Useful as modulators of the interaction between the receptor for advanced glycated end product and its ligands |
| 12/19/2002 | US20020193269 As precursors for organoleptic agents, such as fragrances, and masking agents and for antimicrobial agents |
| 12/19/2002 | CA2449673A1 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity |
| 12/19/2002 | CA2448552A1 Modulators of peroxisome proliferator activated receptors (ppar) |